GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kwang Dong Pharmaceutical Co Ltd (XKRX:009290) » Definitions » Interest Expense

Kwang Dong Pharmaceutical Co (XKRX:009290) Interest Expense : ₩-8,162 Mil (TTM As of Mar. 2024)


View and export this data going back to 1989. Start your Free Trial

What is Kwang Dong Pharmaceutical Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Kwang Dong Pharmaceutical Co's interest expense for the three months ended in Mar. 2024 was ₩ -2,505 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-8,162 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Kwang Dong Pharmaceutical Co's Operating Income for the three months ended in Mar. 2024 was ₩ 17,030 Mil. Kwang Dong Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2024 was ₩ -2,505 Mil. Kwang Dong Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2024 was 6.80. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Kwang Dong Pharmaceutical Co Interest Expense Historical Data

The historical data trend for Kwang Dong Pharmaceutical Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kwang Dong Pharmaceutical Co Interest Expense Chart

Kwang Dong Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,177.13 -2,539.07 -2,543.89 -3,735.30 -6,903.81

Kwang Dong Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,246.94 -1,799.96 -1,939.79 -1,917.12 -2,505.23

Kwang Dong Pharmaceutical Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-8,162 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kwang Dong Pharmaceutical Co  (XKRX:009290) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Kwang Dong Pharmaceutical Co's Interest Expense for the three months ended in Mar. 2024 was ₩-2,505 Mil. Its Operating Income for the three months ended in Mar. 2024 was ₩17,030 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ₩21,338 Mil.

Kwang Dong Pharmaceutical Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2024 )/Interest Expense (Q: Mar. 2024 )
=-1*17029.959/-2505.231
=6.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Kwang Dong Pharmaceutical Co (XKRX:009290) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Kwang Dong Pharmaceutical Co Ltd (XKRX:009290) » Definitions » Interest Expense
Comparable Companies
XKRX:136480 XKRX:072710 XKRX:267980 XKRX:084690 XKRX:194700 XKRX:003920 XKRX:017810 XKRX:003960 XKRX:001130 XKRX:007160 XSWX:NESN KHC GIS XPAR:BN SHSE:603288 NSE:NESTLEIND SZSE:300999 SHSE:600887 TSE:2802 LSE:ABF
Traded in Other Exchanges
N/A
Address
1577-4 Seocho-Dong, Seocho-gu, Seoul, KOR, 137-070
Website
http://www.ekdp.com
Kwang Dong Pharmaceutical Co Ltd is a drug store company. It manufactures and markets medicines and health-aids foods. The company originally focuses on the oriental medicine based drugs but succeeds in health aid beverages. Kwang's products include Vitamins, Antipyretic, Analgesic, Eye drops and amongst others.

Kwang Dong Pharmaceutical Co (XKRX:009290) Headlines

No Headlines